Health Catalyst, Inc. (NASDAQ:HCAT) Stock Has Average Price Target of $2.45 According to Brokerages

Shares of Health Catalyst, Inc. (NASDAQ:HCAT) have earned an average recommendation of “Hold” from the eleven brokerages that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a sell rating, seven have given a hold rating and three have assigned a buy rating to the company. The average 12-month price target among analysts that have updated their coverage on the stock in the last year is $2.45.

Several equities analysts have recently weighed in on the stock. Wells Fargo & Company reduced their price objective on shares of Health Catalyst from $1.75 to $1.50 and set an “equal weight” rating for the company in a research report on Thursday, August 13th. Weiss Ratings raised shares of Health Catalyst from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Tuesday, July 28th. Canaccord Genuity Group restated a “hold” rating and set a $1.80 target price (down from $3.00) on shares of Health Catalyst in a report on Thursday, August 20th. Finally, Citigroup decreased their target price on Health Catalyst from $2.50 to $2.00 and set a “neutral” rating on the stock in a report on Tuesday, August 11th.

Health Catalyst Trading Up 2.9%

Shares of NASDAQ:HCAT opened at $1.75 on Thursday. The company has a 50 day moving average of $1.80 and a 200-day moving average of $1.64. The company has a current ratio of 2.70, a quick ratio of 2.70 and a debt-to-equity ratio of 1.51. The firm has a market cap of $131.71 million, a P/E ratio of -0.48 and a beta of 1.54. Health Catalyst has a twelve month low of $0.96 and a twelve month high of $3.62.

Health Catalyst (NASDAQ:HCAT) last released its earnings results on Thursday, August 6th. The company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. The firm had revenue of $70.49 million during the quarter, compared to the consensus estimate of $69.09 million. Health Catalyst had a negative return on equity of 1.83% and a negative net margin of 90.61%. As a group, analysts anticipate that Health Catalyst will post -0.18 earnings per share for the current fiscal year.

Insider Buying and Selling at Health Catalyst

In other news, CEO Simeon Kohl acquired 59,000 shares of the firm’s stock in a transaction that occurred on Monday, September 14th. The stock was purchased at an average price of $1.79 per share, with a total value of $105,610.00. Following the purchase, the chief executive officer owned 2,856,385 shares of the company’s stock, valued at approximately $5,112,929.15. This trade represents a 2.11% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. 19.40% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Health Catalyst

Several hedge funds have recently bought and sold shares of HCAT. Squarepoint Ops LLC grew its position in Health Catalyst by 1,214.8% during the second quarter. Squarepoint Ops LLC now owns 400,210 shares of the company’s stock valued at $796,000 after purchasing an additional 369,772 shares in the last quarter. AXQ Capital LP purchased a new stake in shares of Health Catalyst during the second quarter worth $38,000. Headlands Technologies LLC acquired a new stake in Health Catalyst during the second quarter valued at $131,000. Hsbc Holdings PLC boosted its position in Health Catalyst by 313.3% during the second quarter. Hsbc Holdings PLC now owns 408,634 shares of the company’s stock valued at $809,000 after purchasing an additional 309,766 shares during the last quarter. Finally, Palogic Value Management L.P. purchased a new position in Health Catalyst in the second quarter valued at about $9,796,000. 85.00% of the stock is owned by hedge funds and other institutional investors.

About Health Catalyst

Health Catalyst, Inc is a healthcare technology and data analytics company that helps healthcare organizations use data to improve clinical outcomes, operational performance and financial results. The company provides software, data management capabilities and professional services designed to support hospitals, health systems, medical groups and other healthcare providers.

Its offerings include the Health Catalyst Data Operating System, which integrates and organizes data from disparate clinical, financial and operational systems, as well as analytics applications for areas such as quality improvement, population health, cost management and care delivery.